328 related articles for article (PubMed ID: 21029020)
41. Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
Mishra D; Sinha BP; Kumar MS
Korean J Ophthalmol; 2014 Oct; 28(5):399-407. PubMed ID: 25276082
[TBL] [Abstract][Full Text] [Related]
42. Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.
Konstas AG; Holló G; Irkec M; Tsironi S; Durukan I; Goldenfeld M; Melamed S
Br J Ophthalmol; 2007 Jun; 91(6):757-60. PubMed ID: 17124241
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
[TBL] [Abstract][Full Text] [Related]
44. Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network.
Loftus J; Christopoulou D; Blak BT; Hards M
Eur J Ophthalmol; 2012; 22(3):376-87. PubMed ID: 22034021
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
Ozturk F; Ermis SS; Inan UU
Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
[TBL] [Abstract][Full Text] [Related]
46. Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial.
Russ HH; Nogueira-Filho PA; Barros Jde N; Faria NV; Montiani-Ferreira F; Gomes JÁ; Mello PA
Clinics (Sao Paulo); 2013 Oct; 68(10):1318-24. PubMed ID: 24212838
[TBL] [Abstract][Full Text] [Related]
47. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
Law SK; Song BJ; Fang E; Caprioli J
Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy.
Kashiwagi K
Jpn J Ophthalmol; 2012 Jul; 56(4):339-45. PubMed ID: 22581454
[TBL] [Abstract][Full Text] [Related]
49. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
50. Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients.
Martinez A; Sanchez M
Eye (Lond); 2009 Apr; 23(4):810-8. PubMed ID: 18535605
[TBL] [Abstract][Full Text] [Related]
51. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
[TBL] [Abstract][Full Text] [Related]
52. Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.
Stewart WC; Kolker AE; Stewart JA; Leech J; Jackson AL
Am J Ophthalmol; 2003 Mar; 135(3):314-20. PubMed ID: 12614748
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.
Chen MJ; Chen YC; Chou CK; Hsu WM
J Ocul Pharmacol Ther; 2007 Dec; 23(6):559-66. PubMed ID: 18001247
[TBL] [Abstract][Full Text] [Related]
54. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
[TBL] [Abstract][Full Text] [Related]
55. Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.
Scherzer ML; Liehneova I; Negrete FJ; Schnober D
Adv Ther; 2011 Aug; 28(8):661-70. PubMed ID: 21773673
[TBL] [Abstract][Full Text] [Related]
56. A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.
Hommer A; Wickstrøm J; Friis MM; Steeds C; Thygesen J; Ferreras A; Gouws P; Buchholz P
Curr Med Res Opin; 2008 Apr; 24(4):1057-63. PubMed ID: 18315942
[TBL] [Abstract][Full Text] [Related]
57. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
Hatanaka M; Reis A; Sano ME; Susanna R
J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
[TBL] [Abstract][Full Text] [Related]
58. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
Chiseliţă D; Antohi I; Medvichi R; Danielescu C
Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674
[TBL] [Abstract][Full Text] [Related]
59. Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study.
Russ HH; Costa VP; Ferreira FM; Valgas SR; Correa Neto MA; Strobel Ev; Truppel JH
Arq Bras Oftalmol; 2007; 70(6):910-6. PubMed ID: 18235898
[TBL] [Abstract][Full Text] [Related]
60. A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.
Sharpe ED; Williams RD; Stewart JA; Nelson LA; Stewart WC
J Ocul Pharmacol Ther; 2008 Aug; 24(4):408-13. PubMed ID: 18627340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
